Blue J Legal Focus of Globe & Mail Article – “Artificial intelligence takes the drudgery out of legal work”

Artificial intelligence takes the drudgery out of legal work For years, budding airplane pilots and race-car drivers have been able to strap themselves into virtual simulators to test their respective skills and odds of real-world success. But what about lawyers? Recent advances in artificial intelligence and machine learning mean legal professionals are now getting the… Read more »

UTEST companies move into new entrepreneurship space – ONRamp!

One of the biggest challenges Albert Tai faced when launching a startup was finding the space to do it. The co-founder of Hypercare, a UTEST company from the 2015 cohort, a communication and collaboration app for doctors, recalls bouncing from classroom to coffee shop at the University of Toronto as he and his team looked for places to… Read more »

Deep Genomics raises US$13 million to fund expansion

Deep Genomics, part of the 2015 UTEST cohort, has raised US$13 million from Khosla Ventures. Deep Genomics combines artificial intelligence and genomics research to help develop genetic medicines to treat a myriad of disorders – everything from autism to cancer. Brendan Frey, CEO and a professor in U of T’s Faculty of Applied Science & Engineering, told the Globe… Read more »

Dalriada Therapeutics Wins RBC Innovation & Entrepreneurship $25K Grand Prize!

Congratulations to Dalriada Therapeutics for winning the inaugural RBC Innovation & Entrepreneurship Prize! CEO Diana Kraskouskaya did a tremendous job telling the Dalriada story and walked away with $25K in prize money. Full event details found here Pictured above: Professor Cynthia Goh, Gabriel Woo, RBC’s vice-president of innovation,  Dalriada CEO, Diana Kraskouskaya and CSO, Professor Patrick Gunning.

UTEST companies are 4 of 6 finalists for RBC Prize for Innovation!

UT Entrepreneurship announced their top 6 finalists for the RBC Prize for Innovation. UTEST will be represented by: Dalriada Therapeutics is developing a unique ‘cloaking’ therapeutic technology for the treatment of most aggressive, currently untreatable cancers including acute myeloid leukaemia, glioblastoma and medulloblastoma. Dash MD is a mobile patient experience platform that improves recovery outcomes by… Read more »

UTEST 2018 Applications To Open Shortly

  UTEST applications for the 2018/2019 cohort will be opening shortly. If you have questions regarding our next application intake please email Kurtis – kurtis.scissons@utoronto.ca

DashMD : New App Gives ED Patients Aftercare Instructions and Med Info

New app gives ED patients aftercare instructions and med info By Andrew Schellenbach Mr. Guido Alvarez, has been to other emergency departments (ED) in the past and found that the aftercare instructions he received upon discharge were not always clear. This can be expected given the fast-paced nature of any ED and the depth of… Read more »

Hammock Therapeutics Co-Founder, Molly Shoichet wins 2016 Till & McCulloch Award

Molly Shoichet awarded 2016 Till & McCulloch Award – U of T Engineering News University Professor Molly Shoichet, a world-renowned researcher and leader in the use of biomaterials to enhance stem-cell delivery for treating disease conditions from stroke to blindness, is the recipient of the 2016 Till & McCulloch Award.